Long-time penicillamine-treatment in Amyotrophic Lateral Sclerosis with parallel determination of lead in blood, plasma and urine
- 1 March 1982
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 65 (3) , 203-211
- https://doi.org/10.1111/j.1600-0404.1982.tb03078.x
Abstract
Six ALS-patients were given long-term penicillamine treatment. A rapid, long-lasting increase in urinary lead was provoked, whereas whole blood and plasma lead were unchanged. In four patients, the progress did not change markedly, one patient deteriorated rapidly and in one patient the progression slowed down after one and a half years of treatment.Keywords
This publication has 17 references indexed in Scilit:
- Epidemiology of amyotrophic lateral sclerosisNeurology, 1980
- Penicillamine‐induced myasthenic responses in the guinea pigMuscle & Nerve, 1979
- PENICILLAMINE IN AMYOTROPHIC LATERAL SCLEROSISThe Lancet, 1979
- Response to penicillamine of lead concentrations in CSF and blood in patients with motor neurone disease.BMJ, 1978
- Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry.Journal of Neurology, Neurosurgery & Psychiatry, 1978
- IMPROVEMENT OF SPINAL AMYOTROPHY BY PENICILLAMINE THERAPYThe Lancet, 1977
- Abnormal tissue distribution of lead in amyotrophic lateral sclerosisJournal of the Neurological Sciences, 1976
- Motor neurone disease and exposure to leadJournal of Neurology, Neurosurgery & Psychiatry, 1970
- Amyotrophic Lateral Sclerosis and Metallic ToxinsArchives of environmental health, 1968
- Treatment of Lead-poisoning with Oral PenicillamineBMJ, 1963